XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities    
Net loss $ (541,746) $ (1,226,664)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 571,707 427,270
Interest from amortization of debt discount    269,844
Interest from amortization of debt costs 1,616 107,494
Gain on sale of property and equipment    (540)
Stock based compensation 137,976 103,900
Change in provision for doubtful accounts receivable 8,557 (2,903)
Deferred rent (59,859) (48,447)
Changes in operating assets and liabilities:    
Trade accounts receivables (8,871) 147,584
Other receivables 30,943   
Inventories (170,059) (323,064)
Prepaid expenses and other assets (30,764) 210,001
Accounts payable and accrued liabilities 317,107 390,747
Net cash provided by (used in) operating activities 256,607 55,222
Cash flows from investing activities    
Purchase of property and equipment (542,597) (631,953)
Proceeds from sale of equipment    540
Net cash used in investing activities (542,597) (631,413)
Cash flows from financing activities    
Proceeds from exercise of stock options    5,653
Proceeds from sale of common stock from employee stock purchase plan 7,871 4,888
Deferred costs associated with equity financing (76,527)   
Costs associated with conversion of debentures    (6,748)
Exercise of warrants    231,659
Net cash provided by (used in) financing activities (68,656) 235,452
Effect of exchange rate on cash and cash equivalents 21,134 (28,316)
Decrease in cash and cash equivalents (333,512) (369,055)
Cash and cash equivalents, beginning of period 928,900 1,464,351
Cash and cash equivalents, end of period 595,388 1,095,296
Supplemental disclosure of cash flow information:    
Interest paid in cash    80
Income taxes paid 3,694 160
Supplemental disclosure of non-cash investing & financing activities:    
Convertible debentures converted into common stock    832,500
Accrued deferred costs associated with equity financing 144,070   
Prepaid interest on convertible debentures through the issuance of common stock $ 87,000